NCT02761564View on ClinicalTrials.gov

SvO2 Trigger in Transfusion Strategy After Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 6, 2016

Primary Completion Date

September 17, 2018

Study Completion Date

October 17, 2018

Conditions
Undergoing Nonemergent Cardiac SurgeryCentral Venous Catheter on the Superior Vena Cava (to Perform ScVO2 Measure)Anemia (<9g/dL) Requiring Blood TransfusionHemodynamic and Respiratory StabilityBleeding Graded as Insignificant, Mild, Moderate of Universal Definition of Perioperative Bleeding
Interventions
OTHER

Red blood cell tranfusion

Red blood cell transfusion according to transfusion guidelines.

OTHER

ScvO2 measure

ScvO2 (oximetry) is measured at the distal lumen of the central venous catheter placed in the superior vena cava. Transfusion is performed if ScvO2 is inferior or equal to 65%.

Trial Locations (1)

Unknown

UHMontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT02761564 - SvO2 Trigger in Transfusion Strategy After Cardiac Surgery | Biotech Hunter | Biotech Hunter